Sage Therapeutics Inc (SAGE)
5.17
+0.32
(+6.60%)
USD |
NASDAQ |
Nov 22, 16:00
5.15
-0.02
(-0.39%)
After-Hours: 20:00
Sage Therapeutics Free Cash Flow: -320.15M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -320.15M |
| June 30, 2024 | -373.65M |
| March 31, 2024 | -424.74M |
| December 31, 2023 | -541.14M |
| September 30, 2023 | -548.94M |
| June 30, 2023 | -531.98M |
| March 31, 2023 | -506.91M |
| December 31, 2022 | -460.97M |
| September 30, 2022 | -431.26M |
| June 30, 2022 | -380.86M |
| March 31, 2022 | -377.06M |
| December 31, 2021 | -378.18M |
| September 30, 2021 | 730.29M |
| June 30, 2021 | 708.10M |
| March 31, 2021 | 691.82M |
| December 31, 2020 | 663.94M |
| September 30, 2020 | -464.14M |
| June 30, 2020 | -503.76M |
| March 31, 2020 | -520.23M |
| December 31, 2019 | -534.46M |
| September 30, 2019 | -519.94M |
| June 30, 2019 | -470.49M |
| Date | Value |
|---|---|
| March 31, 2019 | -335.50M |
| December 31, 2018 | -263.53M |
| September 30, 2018 | -220.65M |
| June 30, 2018 | -185.79M |
| March 31, 2018 | -244.40M |
| December 31, 2017 | -220.64M |
| September 30, 2017 | -195.23M |
| June 30, 2017 | -179.76M |
| March 31, 2017 | -147.78M |
| December 31, 2016 | -120.10M |
| September 30, 2016 | -103.96M |
| June 30, 2016 | -92.59M |
| March 31, 2016 | -83.94M |
| December 31, 2015 | -70.88M |
| September 30, 2015 | -61.44M |
| June 30, 2015 | -49.51M |
| March 31, 2015 | -36.27M |
| December 31, 2014 | -27.17M |
| September 30, 2014 | -23.50M |
| June 30, 2014 | -21.10M |
| March 31, 2014 | -20.10M |
| December 31, 2013 | -17.52M |
Free Cash Flow Range, Past 5 Years
-548.94M
Minimum
Sep 2023
730.29M
Maximum
Sep 2021
-225.21M
Average
-428.00M
Median
Free Cash Flow Benchmarks
| Outset Medical Inc | -126.18M |
| Biogen Inc | 1.768B |
| Johnson & Johnson | 19.02B |
| Lifecore Biomedical Inc | -8.79M |
| Organon & Co | 646.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -82.36M |
| Cash from Investing (Quarterly) | 81.05M |
| Cash from Financing (Quarterly) | 1.037M |
| Free Cash Flow Per Share (Quarterly) | -1.348 |
| Free Cash Flow to Equity (Quarterly) | -82.36M |
| Free Cash Flow Yield | -102.4% |